• Joby Aviation agreed to buy defense technology company Resonant Sciences for about $500 million, expanding its defense business with an EBITDA-positive platform.
• Consideration set at about $450 million in cash, $50 million in Joby common stock; stock price for the equity portion fixed at signing.
• Resonant generated more than $100 million in trailing-12-month revenue, up about 40% year over year, with high-teens adjusted EBITDA margins.
• Resonant is set to become Joby’s dedicated defense unit, keeping the Resonant Sciences name under CEO J. Micah North.
• Closing targeted for the first half of 2027, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Joby Aviation Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-055505), on August 11, 2026, and is solely responsible for the information contained therein.